Browse articles from EyeWorld.org related to the ASCRS Annual Meeting. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Vance Thompson, MD, Refractive editor, discusses highlights of the section and how this issue is “a wonderful invitation to our extended family in ophthalmology and a representation of important topics that will be represented at the Annual Meeting.”
Ophthalmology will see its first major live meeting since the pandemic started with the 2021 ASCRS Annual Meeting. “Just as the live meeting will be reflective of our interesting times, this issue of EyeWorld is a product of our unique year, covering many topics that will help the modern ophthalmologist and glaucoma specialist succeed,” said Nathan Radcliffe, MD, Glaucoma editor.
2020 was supposed to be the year ophthalmologists highlighted all of the advances in cataract and refractive surgery and the patients who benefited from advanced technology. Then, in March 2020, the world was turned upside down. Chief Medical Editor Eric Donnenfeld, MD, reflects on this and looks forward.
The ASCRS Foundation announced Geoff Tabin, MD, and Sanduk Ruit, MD, as the 2021 Chang-Crandall Humanitarian Award winners. Endowed by a generous gift from David and Victoria Chang, the ASCRS Foundation Chang-Crandall Humanitarian Award recognizes outstanding humanitarian work with a focus on cataract blindness and disability.
ASCRS announced that the 2021 Annual Meeting will be held July 23–27 in Las Vegas, Nevada, moving from the previous location of San Francisco, California. The move to Las Vegas allows ASCRS to have its first meeting in 800+ days in as safe a meeting venue as can be reasonably organized.
➤ 2021 ASCRS Annual Meeting update ➤ FDA approves new monofocal IOL ➤ First patient dosed in Phase 2 trial for investigational DED therapy ➤ Phase 2a trial initiated for add-on wet AMD therapy
Get the latest ophthalmology news delivered to your inbox every Friday.